Chip Identifies Toxicity as a Biological Quality
|
By LabMedica International staff writers Posted on 30 Jul 2012 |

Image: Scientists have combined biology and engineering to produce a biosensor device called the "Dip Chip," which detects toxicity quickly and accurately, generating low false positive and false negative readings (Photo courtesy of Tel Aviv University).
A biosensor detects toxicity quickly and accurately, generating low false positive and false negative readings.
Called the Dip Chip, the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals.
Invented by Prof. Yosi Shacham-Diamand, vice dean of Tel Aviv University's Faculty of Engineering (Ramat Aviv, Israel) together with Prof. Shimshon Belkin of the Institute of Life Sciences at the Hebrew University of Jerusalem (Givat Ram, Jerusalem, Israel), the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals. The biological reaction is converted into an electronic signal that can be read by the user.
"In my lab, we developed a method for communicating with the microbes, converting this biological response to electrical signals," Prof. Shacham-Diamand explained. The device, which looks like a dipstick, immobilizes these specially produced microbes next to the sensing electrodes. Once the microbes come into contact with a questionable substance they produce a chemical signal that is converted to an electrical current by a device that can interpret the signals, producing a binary toxic or not toxic diagnosis.
The new chips are based on genetically modified microbes developed in Prof. Belkin's lab. When the modified microbes are exposed to toxic or poisonous materials, they produce a measurable biochemical reaction, which is converted into to electrical signals.
The Dip Chip is designed to alert the user to overall toxicity. Because the chip measures general toxicity, it will pick up on any and all toxic materials -- even those that have not been discovered or invented. Beyond their ability to find toxic chemicals in the field, these chips can also be put to use in the cosmetics or pharmaceutical industries, said Prof. Shacham-Diamand.
Related Links:
Tel Aviv University's Faculty of Engineering
Institute of Life Sciences at the Hebrew University of Jerusalem
Called the Dip Chip, the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals.
Invented by Prof. Yosi Shacham-Diamand, vice dean of Tel Aviv University's Faculty of Engineering (Ramat Aviv, Israel) together with Prof. Shimshon Belkin of the Institute of Life Sciences at the Hebrew University of Jerusalem (Givat Ram, Jerusalem, Israel), the device contains microbes designed to exhibit a biological reaction to toxic chemicals, emulating the biological responses of humans or animals. The biological reaction is converted into an electronic signal that can be read by the user.
"In my lab, we developed a method for communicating with the microbes, converting this biological response to electrical signals," Prof. Shacham-Diamand explained. The device, which looks like a dipstick, immobilizes these specially produced microbes next to the sensing electrodes. Once the microbes come into contact with a questionable substance they produce a chemical signal that is converted to an electrical current by a device that can interpret the signals, producing a binary toxic or not toxic diagnosis.
The new chips are based on genetically modified microbes developed in Prof. Belkin's lab. When the modified microbes are exposed to toxic or poisonous materials, they produce a measurable biochemical reaction, which is converted into to electrical signals.
The Dip Chip is designed to alert the user to overall toxicity. Because the chip measures general toxicity, it will pick up on any and all toxic materials -- even those that have not been discovered or invented. Beyond their ability to find toxic chemicals in the field, these chips can also be put to use in the cosmetics or pharmaceutical industries, said Prof. Shacham-Diamand.
Related Links:
Tel Aviv University's Faculty of Engineering
Institute of Life Sciences at the Hebrew University of Jerusalem
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read more
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more




.jpg)



